Log in

OTCMKTS:CVSICV Sciences News Headlines

$0.68
-0.11 (-13.61 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.65
Now: $0.68
$0.80
50-Day Range
$0.52
MA: $0.60
$0.79
52-Week Range
$0.25
Now: $0.68
$3.90
Volume777,271 shs
Average Volume397,973 shs
Market Capitalization$68.29 million
P/E RatioN/A
Dividend YieldN/A
Beta0.25

Headlines

CV Sciences (OTCMKTS CVSI) News Headlines

Source:
DateHeadline
CV Sciences EPS misses by $0.02, misses on revenueCV Sciences EPS misses by $0.02, misses on revenue
seekingalpha.com - August 6 at 6:33 PM
CV Sciences, Inc. Reports Second Quarter 2020 Financial ResultsCV Sciences, Inc. Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 6 at 6:33 PM
CV Sciences, Inc. Announces Launch of Happy Lane™ CBD Product LineCV Sciences, Inc. Announces Launch of Happy Lane™ CBD Product Line
finance.yahoo.com - August 5 at 11:12 AM
CV Sciences (CVSI) to Release Quarterly Earnings on ThursdayCV Sciences (CVSI) to Release Quarterly Earnings on Thursday
americanbankingnews.com - August 5 at 10:04 AM
CV Sciences Inc (OTCMKTS:CVSI) Receives Average Recommendation of "Buy" from BrokeragesCV Sciences Inc (OTCMKTS:CVSI) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - August 1 at 9:48 AM
CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product LineCV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line
finance.yahoo.com - July 29 at 12:36 PM
CV Sciences, Inc. to Announce Second Quarter 2020 Results on August 6, 2020CV Sciences, Inc. to Announce Second Quarter 2020 Results on August 6, 2020
finance.yahoo.com - July 23 at 7:06 PM
CV Sciences, Inc. Announces Publication of Two Research Studies Demonstrating the Safety and Health Benefits of PlusCBD™ ProductsCV Sciences, Inc. Announces Publication of Two Research Studies Demonstrating the Safety and Health Benefits of PlusCBD™ Products
finance.yahoo.com - June 2 at 1:36 PM
CBD Infused Beverages Market Size Expected to Reach $2.8 Billion by 2025CBD Infused Beverages Market Size Expected to Reach $2.8 Billion by 2025
www.prnewswire.com - May 27 at 8:59 AM
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco AddictionCV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction
finance.yahoo.com - May 20 at 9:44 AM
CV Sciences: The CBD Hype Is Fading AwayCV Sciences: The CBD Hype Is Fading Away
seekingalpha.com - May 11 at 5:20 PM
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2020 Results - Earnings Call TranscriptCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 6:50 PM
CV Sciences EPS in-line, beats on revenueCV Sciences EPS in-line, beats on revenue
seekingalpha.com - May 8 at 1:49 PM
CV Sciences, Inc. Reports First Quarter 2020 Financial ResultsCV Sciences, Inc. Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 8 at 1:49 PM
CV Sciences Inc (CVSI) Reports Q1 Loss, Tops Revenue EstimatesCV Sciences Inc (CVSI) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 8 at 1:49 PM
Analysts Estimate CV Sciences, Inc.
(CVSI) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate CV Sciences, Inc. (CVSI) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 6 at 11:31 PM
CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2020CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2020
finance.yahoo.com - April 30 at 6:03 PM
BRIEF-CV Sciences Files For Mixed Shelf Of Up To $100 MillionBRIEF-CV Sciences Files For Mixed Shelf Of Up To $100 Million
www.reuters.com - April 23 at 2:04 PM
CV Sciences, Inc. Announces Filing of Form S-3 Shelf Registration StatementCV Sciences, Inc. Announces Filing of Form S-3 Shelf Registration Statement
finance.yahoo.com - April 22 at 9:32 AM
CV Sciences, Inc. Receives Notice of Patent Allowance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco AddictionCV Sciences, Inc. Receives Notice of Patent Allowance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction
finance.yahoo.com - April 6 at 5:41 PM
CV Sciences, Inc. (CVSI) Upgraded to Buy: What Does It Mean for the Stock?CV Sciences, Inc. (CVSI) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - March 19 at 1:40 PM
Edited Transcript of CVSI earnings conference call or presentation 16-Mar-20 8:30pm GMTEdited Transcript of CVSI earnings conference call or presentation 16-Mar-20 8:30pm GMT
finance.yahoo.com - March 17 at 8:41 PM
CV Sciences EPS misses by $0.01, misses on revenueCV Sciences EPS misses by $0.01, misses on revenue
seekingalpha.com - March 16 at 10:29 PM
CV Sciences, Inc. (CVSI) Reports Q4 Loss, Lags Revenue EstimatesCV Sciences, Inc. (CVSI) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 16 at 10:29 PM
CV Sciences, Inc. Reports Fiscal Year-End 2019 Financial ResultsCV Sciences, Inc. Reports Fiscal Year-End 2019 Financial Results
finance.yahoo.com - March 16 at 5:28 PM
CV SCIENCES, INC. RESCHEDULES FULL YEAR 2019 RESULTS CONFERENCE CALL TO MARCH 16, 2020CV SCIENCES, INC. RESCHEDULES FULL YEAR 2019 RESULTS CONFERENCE CALL TO MARCH 16, 2020
finance.yahoo.com - March 10 at 6:22 PM
CV Sciences Inc.CV Sciences Inc.
www.barrons.com - March 8 at 9:09 AM
Earnings Preview: CV Sciences, Inc. (CVSI) Q4 Earnings Expected to DeclineEarnings Preview: CV Sciences, Inc. (CVSI) Q4 Earnings Expected to Decline
finance.yahoo.com - March 3 at 1:38 PM
CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020
finance.yahoo.com - February 26 at 8:26 AM
CV Sciences IncCV Sciences Inc
www.bloomberg.com - February 21 at 10:58 PM
Consumers Clamor for CBD as More Novel Uses are PurportedConsumers Clamor for CBD as More Novel Uses are Purported
www.finanznachrichten.de - February 11 at 11:19 AM
CV SCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL:  Kahn Swick & Foti, LLC Investigates the Officers and Directors of CV Sciences, Inc. - CVSICV SCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CV Sciences, Inc. - CVSI
finance.yahoo.com - January 25 at 5:20 AM
CV Sciences, Inc. Launches Updated +PlusCBD™ Oil Website to Enhance User Experience and Drive Increased E-Commerce SalesCV Sciences, Inc. Launches Updated +PlusCBD™ Oil Website to Enhance User Experience and Drive Increased E-Commerce Sales
finance.yahoo.com - January 23 at 4:41 PM
3 CBD Stocks to Benefit From Passage of a CBD Bill3 CBD Stocks to Benefit From Passage of a CBD Bill
finance.yahoo.com - January 22 at 3:56 PM
Farmers Insurance Open Selects +PlusCBD™ Oil as Their First-Ever CBD SponsorFarmers Insurance Open Selects +PlusCBD™ Oil as Their First-Ever CBD Sponsor
finance.yahoo.com - January 21 at 5:39 PM
CV Sciences (CVSI) Presents At 22nd Annual ICR Xchange Conference - SlideshowCV Sciences (CVSI) Presents At 22nd Annual ICR Xchange Conference - Slideshow
seekingalpha.com - January 15 at 11:20 PM
CV Sciences: What Went Wrong?CV Sciences: What Went Wrong?
seekingalpha.com - January 10 at 3:16 PM
CV Sciences, Inc. to Participate at the 22nd Annual ICR ConferenceCV Sciences, Inc. to Participate at the 22nd Annual ICR Conference
finance.yahoo.com - January 8 at 4:08 PM
Buoyed Cannabis Sales Push Agencies to Bolster Oversight of its UseBuoyed Cannabis Sales Push Agencies to Bolster Oversight of its Use
www.finanznachrichten.de - January 7 at 4:09 PM
Tim Hitchman, PhD, Joins CV Sciences, Inc. as Director of OperationsTim Hitchman, PhD, Joins CV Sciences, Inc. as Director of Operations
finance.yahoo.com - December 17 at 8:51 AM
CV SCIENCES INVESTIGATION INITIATED By Former...CV SCIENCES INVESTIGATION INITIATED By Former...
www.benzinga.com - December 13 at 11:53 PM
CV SCIENCES INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CV Sciences, Inc. - CVSICV SCIENCES INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CV Sciences, Inc. - CVSI
finance.yahoo.com - December 13 at 11:53 PM
CV Sciences to Present at the 12th Annual LD Micro Main EventCV Sciences to Present at the 12th Annual LD Micro Main Event
finance.yahoo.com - December 3 at 1:38 PM
7 Marijuana Penny Stocks That Have Ridiculous Possibilities7 Marijuana Penny Stocks That Have Ridiculous Possibilities
finance.yahoo.com - November 28 at 2:23 AM
CV Sciences: The Best Defense Is OffenseCV Sciences: The Best Defense Is Offense
seekingalpha.com - November 27 at 3:10 PM
CV Sciences: Revising Our Bull ThesisCV Sciences: Revising Our Bull Thesis
seekingalpha.com - November 11 at 10:56 PM
Cantor likes CV Sciences in premarket analyst actionCantor likes CV Sciences in premarket analyst action
seekingalpha.com - November 8 at 9:06 AM
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q3 2019 Results - Earnings Call TranscriptCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 10:50 PM
CV Sciences, Inc. (CVSI) Reports Q3 Loss, Misses Revenue EstimatesCV Sciences, Inc. (CVSI) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 5 at 10:50 PM
CV Sciences, Inc. Reports Third Quarter 2019 Financial ResultsCV Sciences, Inc. Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 5 at 5:50 PM
This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.